Chemoprevention trial of acitretin versus placebo in solid organ transplant recipients with multiple prior treated skin cancers

Trial Profile

Chemoprevention trial of acitretin versus placebo in solid organ transplant recipients with multiple prior treated skin cancers

Discontinued
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2011

At a glance

  • Drugs Acitretin (Primary)
  • Indications Basal cell cancer; Skin cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2011 Results published in Cancer.
    • 31 Aug 2011 Primary endpoint 'Disease-occurrence-rate' has not been met.
    • 24 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top